These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31650979)

  • 1. A short, 8-week course of imiquimod 5% cream versus podophyllotoxin in the treatment of anogenital warts: A retrospective comparative cohort study.
    Nicolaidou E; Kanelleas A; Nikolakopoulos S; Bezrodnii G; Nearchou E; Gerodimou M; Papadopoulou-Skordou E; Paparizos V; Rigopoulos D
    Indian J Dermatol Venereol Leprol; 2021; 87(5):666-670. PubMed ID: 31650979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
    Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
    Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts.
    Komericki P; Akkilic-Materna M; Strimitzer T; Aberer W
    Sex Transm Dis; 2011 Mar; 38(3):216-8. PubMed ID: 20938374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the treatment of external anogenital warts in France].
    Lafuma A; Monsonego J; Moyal-Barracco M; Pribil C
    Ann Dermatol Venereol; 2003; 130(8-9 Pt 1):731-6. PubMed ID: 14576602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial).
    Murray ML; Meadows J; Doré CJ; Copas AJ; Haddow LJ; Lacey C; Jit M; Soldan K; Bennett K; Tetlow M; Nathan M; Gilson R
    BMC Med Res Methodol; 2018 Nov; 18(1):125. PubMed ID: 30400777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
    Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
    Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
    Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of anogenital warts in children with topical 0.05% podofilox gel and 5% imiquimod cream.
    Moresi JM; Herbert CR; Cohen BA
    Pediatr Dermatol; 2001; 18(5):448-50; discussion 452. PubMed ID: 11737696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentre, randomised, double-blind, placebo controlled study of cryotherapy versus cryotherapy and podophyllotoxin cream as treatment for external anogenital warts.
    Gilson RJ; Ross J; Maw R; Rowen D; Sonnex C; Lacey CJ
    Sex Transm Infect; 2009 Dec; 85(7):514-9. PubMed ID: 19700413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical imiquimod: a review of its use in genital warts.
    Perry CM; Lamb HM
    Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of 5% imiquimod and 0.5% podophyllotoxin in the treatment of condylomata acuminata.
    Yan J; Chen SL; Wang HN; Wu TX
    Dermatology; 2006; 213(3):218-23. PubMed ID: 17033171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive condyloma acuminata treated with imiquimod 5% cream: a case report.
    Cox JT
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():51-4. PubMed ID: 14616817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New treatments for genital warts less than ideal: abstract and commentary.
    Fife KH
    JAMA; 1998 Jun; 279(24):2003-4. PubMed ID: 9643868
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical aspects and therapy of anogenital warts and papillomavirus-associated lesions].
    Gross G
    Hautarzt; 2001 Jan; 52(1):6-17. PubMed ID: 11220242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions.
    Carrasco D; vander Straten M; Tyring SK
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S212-6. PubMed ID: 12271280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
    Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for the response to treatment in males with genital warts.
    Stefanaki C; Hadjivassiliou M; Katzouranis I; Bethimoutis G; Nicolaidou E; Anyfantakis V; Lagogianni E; Caroni C; Panagiotopoulos A; Antoniou C; Katsambas A
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1156-60. PubMed ID: 19453776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of daily self-application of imiquimod 3.75% cream in adult patients with external anogenital warts.
    Wu J; Feldman R; Barry GT; Kulp J; Adams MP; Levy S
    J Clin Pharmacol; 2012 Jun; 52(6):828-36. PubMed ID: 22232733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of 0.5% podofilox solution in the treatment and suppression of anogenital warts.
    Bonnez W; Elswick RK; Bailey-Farchione A; Hallahan D; Bell R; Isenberg R; Stoler MH; Reichman RC
    Am J Med; 1994 May; 96(5):420-5. PubMed ID: 8192173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of 0.5% podofilox gel in the treatment of anogenital warts.
    Tyring S; Edwards L; Cherry LK; Ramsdell WM; Kotner S; Greenberg MD; Vance JC; Barnum G; Dromgoole SH; Killey FP; Toter T
    Arch Dermatol; 1998 Jan; 134(1):33-8. PubMed ID: 9449907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.